PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+22.49%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$167M
AUM Growth
+$167M
(+19%)
Cap. Flow
+$9.05M
Cap. Flow
% of AUM
5.44%
Top 10 Holdings %
Top 10 Hldgs %
31.97%
Holding
144
New
17
Increased
44
Reduced
38
Closed
12
Top Buys
| 1 |
Venus Concept
VERO
|
$1.73M |
| 2 |
Champions Oncology
CSBR
|
$1.36M |
| 3 |
Sensus Healthcare
SRTS
|
$1.26M |
| 4 |
IRIDEX
IRIX
|
$990K |
| 5 |
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
|
$983K |
Top Sells
| 1 |
Tactile Systems Technology
TCMD
|
$1.29M |
| 2 |
IVTY
Invuity, Inc
IVTY
|
$1.22M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$1.08M |
| 4 |
Cibus
CBUS
|
$833K |
| 5 |
OIG
Orbital Infrastructure Group, Inc. Common Stock
OIG
|
$544K |
Sector Composition
| 1 | Healthcare | 60.63% |
| 2 | Technology | 11.46% |
| 3 | Industrials | 6.55% |
| 4 | Communication Services | 4.39% |
| 5 | Consumer Discretionary | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBE
26
DELISTED
Cyberoptics Corp
CYBE
| $1.9M | 1.14% |
94,250
+18,900
| +25% | +$382K |
|
27
ANI Pharmaceuticals
ANIP
$2.06B
| $1.86M | 1.12% |
32,950
+1,950
| +6% | +$110K |
|
28
Rockwell Medical
RMTI
$59.6M
| $1.77M | 1.06% |
418,500
+7,500
| +2% | +$31.6K |
|
|
29
Venus Concept
VERO
$4.07M
| $1.73M | 1.04% |
+595,000
| New | +$1.73M |
|
30
Aflac
AFL
$57.1B
| $1.64M | 0.98% |
34,850
| – | – |
|
31
Standard BioTools
LAB
$493M
| $1.64M | 0.98% |
218,500
+49,500
| +29% | +$371K |
|
32
Target
TGT
$42B
| $1.63M | 0.98% |
18,450
| – | – |
|
33
Natera
NTRA
$23B
| $1.54M | 0.93% |
64,500
+38,900
| +152% | +$931K |
|
|
PFIE
34
DELISTED
Profire Energy, Inc
PFIE
| $1.54M | 0.92% |
482,025
-3,500
| -0.7% | -$11.2K |
|
|
ATRS
35
DELISTED
Antares Pharma, Inc.
ATRS
| $1.46M | 0.88% |
435,000
+117,500
| +37% | +$395K |
|
|
CGRN
36
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $1.46M | 0.87% |
1,457,143
+305,000
| +26% | +$305K |
|
37
Donaldson
DCI
$9.28B
| $1.45M | 0.87% |
24,900
-1,250
| -5% | -$72.8K |
|
|
38
IRIDEX
IRIX
$23.6M
| $1.45M | 0.87% |
227,950
+156,000
| +217% | +$990K |
|
39
CVS Health
CVS
$93B
| $1.43M | 0.86% |
18,200
+250
| +1% | +$19.7K |
|
|
BBQ
40
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.36M | 0.82% |
207,853
-16,611
| -7% | -$109K |
|
41
Boston Scientific
BSX
$159B
| $1.34M | 0.81% |
34,900
| – | – |
|
|
VYNT
42
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.34M | 0.8% |
1,287,250
+282,700
| +28% | +$294K |
|
|
BREW
43
DELISTED
Craft Brew Alliance, Inc.
BREW
| $1.28M | 0.77% |
78,200
+13,600
| +21% | +$222K |
|
|
VG
44
DELISTED
Vonage Holdings Corporation
VG
| $1.27M | 0.76% |
89,725
+900
| +1% | +$12.7K |
|
|
HTGM
45
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.26M | 0.76% |
249,700
| – | – |
|
46
AT&T
T
$208B
| $1.18M | 0.71% |
35,262
+500
| +1% | +$16.8K |
|
47
IZEA Worldwide
IZEA
$61.1M
| $1.17M | 0.7% |
735,695
-91,900
| -11% | -$146K |
|
48
Bristol-Myers Squibb
BMY
$96.7B
| $1.15M | 0.69% |
18,500
-500
| -3% | -$31K |
|
|
TBCH
49
Turtle Beach Corporation Common Stock
TBCH
$294M
| $1.06M | 0.63% |
53,006
-5,576
| -10% | -$111K |
|
50
Expeditors International
EXPD
$16.3B
| $1.03M | 0.62% |
14,000
| – | – |
|